Profile data is unavailable for this security.
About the company
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
- Revenue in USD (TTM)6.00k
- Net income in USD-5.96m
- Incorporated1998
- Employees4.00
- LocationCreative Medical Technology Holdings Inc211 E. Osborn Rd.PHOENIX 85012United StatesUSA
- Phone+1 (480) 399-2822
- Websitehttps://creativemedicaltechnology.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Silexion Therapeutics Corp | 0.00 | -9.25m | 5.54m | 11.00 | -- | 0.7449 | -- | -- | -25.21 | -25.21 | 0.00 | 2.23 | 0.00 | -- | -- | 0.00 | -125.80 | -- | -221.96 | -- | -- | -- | -- | -- | -- | -84.50 | 0.1808 | -- | -- | -- | -223.39 | -- | -- | -- |
| Processa Pharmaceuticals Inc | 0.00 | -12.93m | 5.76m | 10.00 | -- | 0.9207 | -- | -- | -35.00 | -35.00 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -206.50 | -104.23 | -270.68 | -112.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.55 | -- | -- | -- |
| StimCell Enegetics Inc | 0.00 | -935.22k | 5.87m | 0.00 | -- | -- | -- | -- | -0.0461 | -0.0461 | 0.00 | -0.0738 | 0.00 | -- | -- | -- | -2,062.23 | -844.03 | -- | -- | -- | -- | -- | -18,037.46 | -- | -17.22 | -- | -- | -- | -- | -297.42 | -- | -- | -- |
| Aprea Therapeutics Inc | 488.24k | -13.04m | 5.94m | 8.00 | -- | 0.4652 | -- | 12.16 | -2.14 | -2.14 | 0.08 | 1.95 | 0.0237 | -- | -- | 61,030.00 | -63.27 | -81.97 | -74.72 | -94.17 | -- | -- | -2,670.56 | -11,051.52 | -- | -- | 0.00 | -- | 157.63 | -- | 9.30 | -- | -12.91 | -- |
| BioNexus Gene Lab Corp | 9.47m | -2.30m | 5.98m | 30.00 | -- | 0.6669 | -- | 0.6319 | -1.28 | -1.28 | 5.27 | 3.79 | 1.02 | 6.73 | 6.42 | -- | -24.68 | -6.00 | -27.80 | -7.75 | 14.77 | 14.31 | -24.27 | -4.98 | 6.81 | -1,354.05 | 0.00 | -- | -2.66 | 137.09 | 39.20 | -- | 77.67 | -- |
| Moleculin Biotech Inc | 0.00 | -41.36m | 6.11m | 17.00 | -- | -- | -- | -- | -55.88 | -55.88 | 0.00 | -13.60 | 0.00 | -- | -- | 0.00 | -189.07 | -49.52 | -254.72 | -54.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 26.89 | -- | -24.21 | -- |
| Hi-Great Group Holding Co | 48.03k | -64.27k | 6.15m | -- | -- | -- | -- | 128.05 | -0.0006 | -0.0006 | 0.0005 | -0.002 | 0.7229 | 0.5559 | -- | -- | -96.73 | -21.81 | -- | -256.35 | 38.77 | 45.63 | -133.81 | -21.02 | 0.0288 | -- | -- | -- | -36.79 | -- | 60.07 | -- | -- | -- |
| Creative Medical Technology Holdings Inc | 6.00k | -5.96m | 6.22m | 4.00 | -- | 0.8215 | -- | 1,036.75 | -2.87 | -2.87 | 0.0027 | 2.17 | 0.0009 | 1.10 | -- | 1,500.00 | -93.58 | -83.62 | -98.14 | -- | 60.00 | 62.58 | -99,356.66 | -10,541.10 | 20.70 | -- | 0.00 | -- | 22.22 | -41.85 | -3.91 | -- | -- | -- |
| Aptorum Group Ltd | -100.00bn | -100.00bn | 6.46m | 1.00 | -- | 0.2514 | -- | -- | -- | -- | -- | 3.15 | -- | -- | -- | -- | -- | -33.06 | -- | -31.53 | -- | 1.65 | -- | -1,009.86 | -- | -- | 0.2079 | -- | -100.00 | -- | -51.09 | -- | -- | -- |
| Bullfrog AI Holdings Inc | 116.67k | -6.76m | 6.50m | 9.00 | -- | 3.05 | -- | 55.74 | -0.6936 | -0.6936 | 0.0119 | 0.1866 | 0.0319 | -- | -- | 12,963.33 | -184.34 | -- | -233.50 | -- | 18.76 | -- | -5,770.66 | -- | -- | -- | 0.0278 | -- | -100.00 | -- | -31.42 | -- | -- | -- |
| Intelligent Bio Solutions Inc | 3.58m | -11.29m | 6.58m | 16.00 | -- | 0.4577 | -- | 1.84 | -15.13 | -15.13 | 4.65 | 8.96 | 0.272 | 2.98 | 9.91 | 223,832.50 | -86.08 | -73.55 | -132.01 | -123.30 | 46.21 | -- | -316.50 | -476.22 | 2.26 | -241.14 | 0.0012 | -- | -1.90 | 74.49 | -4.06 | -- | -- | -- |
| Aptevo Therapeutics Inc | 0.00 | -27.95m | 6.65m | 37.00 | -- | 0.2938 | -- | -- | -306,220.00 | -306,220.00 | 0.00 | 22.67 | 0.00 | -- | -- | 0.00 | -125.64 | -47.17 | -172.77 | -82.66 | -- | -- | -- | -487.43 | -- | -- | 0.00 | -- | -- | -- | -29.38 | -- | -- | -- |
| Mustang Bio Inc | 0.00 | -2.34m | 6.76m | 6.00 | -- | 0.6915 | -- | -- | -47.37 | -47.37 | 0.00 | 1.34 | 0.00 | -- | -- | 0.00 | -17.59 | -70.16 | -224.95 | -83.31 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 69.47 | -- | -- | -- |
| Theriva Biologics Inc | 0.00 | -26.19m | 6.77m | 22.00 | -- | 0.29 | -- | -- | -5.53 | -5.53 | 0.00 | 0.6539 | 0.00 | -- | -- | 0.00 | -73.83 | -37.94 | -99.55 | -42.02 | -- | -- | -- | -- | -- | -- | 0.2025 | -- | -- | -- | -39.81 | -- | -- | -- |
Data as of Mar 03 2026. Currency figures normalised to Creative Medical Technology Holdings Inc's reporting currency: US Dollar USD
4.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Jane Street Capital LLCas of 31 Dec 2025 | 30.21k | 1.17% |
| Geode Capital Management LLCas of 31 Dec 2025 | 28.47k | 1.10% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 20.35k | 0.79% |
| Citadel Securities LLCas of 31 Dec 2025 | 17.46k | 0.68% |
| DRW Securities LLCas of 31 Dec 2025 | 10.32k | 0.40% |
| Global Retirement Partners LLCas of 31 Dec 2025 | 7.92k | 0.31% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 5.52k | 0.21% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Dec 2025 | 5.11k | 0.20% |
| Tower Research Capital LLCas of 31 Dec 2025 | 2.32k | 0.09% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 1.13k | 0.04% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
